Genomma Provides Underwhelming Financial Guidance

BMI View: When pharmaceutical companies enter a new market they should make sure their products fit the market needs and tailor their strategic endeavours to avoid unnecessary costs, which can undermine the benefits of territorial expansion. In addition, multinational drugmakers have to monitor the global economic situation, as well as hedge their foreign currency

To read the full article, please choose one of the following options: